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with knee OA who underwent joint replacement surgery. Using quiescent
cells stimulated with 10U/mL of Il-1b, the effects of NAC (2mmol/L)
on prostaglandin E2 (PGE2) production, cyclooxigenase-2 (COX-2) ex-
pression, nitric oxide (NO) synthesis, nuclear factor kappa B (NF-kB)
activation, and metalloproteinase (MMP)-1 and MMP-13 presence were
studied. NAC was tested at mean peak plasma level (Cmax) obtained
after oral administration of therapeutic doses.
Results: NAC did not induce a direct effect on basal cell expression
of the molecules assessed at the levels and incubation periods used.
NAC inhibited Il-1b stimulated NF-kB activation both in synoviocytes and
chondrocytes. NAC diminished PGE-2 release and the protein expression
of COX-2 in synoviocytes stimulated with Il-1b, but it failed to modify this
expression in stimulated chondrocytes. The incubation of chondrocytes
with NAC did not inhibit the effect of Il-1b on NO synthesis. Neither
quiescent nor Il-1b stimulated synoviocytes rendered detectable NO
levels at supernatants of cell culture after 24 h of incubation. With regard
to structural mediators, NAC signiﬁcantly decreased MMP-13 levels in
Il-1b stimulated synoviocytes. NAC did not induce changes in MMP-1
protein expression as compared with Il-1b-stimulated synoviocytes and
chondrocytes.
Conclusions: NAC inhibited Il-1b stimulated NF-kB activation in syn-
oviocytes and chondrocytes. While NAC had an evident effect in terms of
reducing the synthesis of several proinﬂammatory and structural media-
tors by synovial cells, it lacked of effects on chondrocytes. These results
suggest that, in the event this molecule could be used for OA treatment,
it would have a symptomatic effect at the synovial membrane level rather
than a structural effect at the cartilage level.
169 COMBINED EXPRESSION OF INSULIN-LIKE GROWTH
FACTOR-1 AND INTERLEUKIN-4 STRENGTHENS THE
REGENERATIVE AND ANTI-INFLAMMATORY EFFECTS IN
CANINE ARTICULAR CHONDROCYTES IN-VITRO
K. Manning-Kroeger, M.F. Rai, M.F. Schmidt. Institute of Immunology
and Molecular Biology, Berlin, GERMANY
Purpose: Insulin-like growth factor-1 can stimulate the synthesis of
cartilage matrix proteins, namely the proteoglycan aggrecan. The action
of IGF-1 is modulated locally by IGF-binding proteins (IGFBPs). Catabolic
mediators Il-1b and TNF-a have been implicated in the pathology of
inﬂammatory and degenerative arthritis and also have been shown to
induce the production of IGFBPs. Interleukin-4 (IL4) has been proven to
down-regulate the catabolic affects of both Il-1b and TNF-a. The aims
of the present study were to regulate the effects of pro-inﬂammatory
cytokines by limiting the effects of the degenerative and inﬂammatory
pathways through the co-expression of IGF-1 and IL4.
Methods: Canine articular chondrocytes (CACs) were obtained from
articular cartilage harvested from young dogs and cultivated for a total
of 42 days. Canine speciﬁc IGF-1 and IL4 were cloned into a dual
expression eukaryotic vector and transfected into CACs. Inﬂammation
was stimulated in-vitro with canine speciﬁc Il-1b and TNF-a. RNA was
extracted from these cells and then subjected to real-time RT-PCR. ELISA
was preformed to determine the concentration of IL4 present in the cell
lysate. Nitrite concentration was determined in conditioned medium by
using a spectrophotometric assay based on the Griess reaction.
Results: Stimulated transfected CACs showed an increased expression
of proteoglycan aggrecan and SOX-9 indicating synthesis of cartilage
regeneration. Expression of IGF-1 alone increased the expression of
IGFBP2-, -3, -4, -5, and -6 as well as IGFR1. Co-expression of IGF-1
and IL4 led to a minimization of the expression of the binding proteins
2, 5, and 6 as well as MMP-1, -3, and -13 levels. Also NO levels were
decreased in CACs transfected with both IGF-1 and IL4. No change in
the NO levels was detected in cells transfected with IGF-1 alone.
Conclusions: The results show that IGF-1 in combination with IL4 could
stimulate the expression of aggrecan and the transcription factor, SOX-9.
Also, IGF-1/IL4 transfected cells counteracted the pro-inﬂammatory ef-
fects of Il-1b and TNF-a shown by a reduced expression of MMP-1, -3,
and -13 as well as reduced NO levels. Based on the results, co-expression
of IL4 and IGF-1 is ideal to stimulate regenerative and anti-inﬂammatory
genes and may possibly pave the way for future gene therapy studies in
the area of osteoarthritis.
170 INTERLEUKIN-8 EXPRESSION IS MODULATED BY
MITOCHONDRIAL DYSFUNCTION IN CULTURED NORMAL
HUMAN CHONDROCYTES
C. Vaamonde-Garcia, N. Valcarcel-Ares, R. Riveiro-Naviera,
B. Carames, B. Lema, L. Hermida, F.J. Blanco, M.J. Lopez-Armada.
INIBIC-CH Universitario Juan Canalejo, A Corun˜a, SPAIN
Purpose: Mitochondrial alterations may contribute to the progression
of osteoarthritis (OA). Il-8 is an important mediator in the inﬂamma-
tory process and cartilage degradation in OA. In this study, we have
investigated the relationship between the dysfunction of mitochondrial
respiratory chain (MRC) and in vitro expression of Il-8 in cultured normal
human chondrocytes.
Methods: Normal human chondrocytes were isolated from knee cartilage
obtained from necropsy from 12 adult cadavers (mean age 43 years).
Antimycin A (AA) (10, 20 and 40mg/ml) and Oligomycin (5, 10 and
20mg/ml) were employed as inhibitor of the complex III and V of MRC,
respectively, to induce a model of mitochondrial dysfunction. Protein and
mRNA Il-8 expression were analyzed by cytometry, ELISA and real time
PCR. As a positive control, Il-8 expression was induced by Interleukin-1b
(Il-1b; 1.5 ng/ml). In order to identify underlying mechanisms responsible
for Il-8 expression, BAY-117085 (5mM) and N-Acetyl-L-Cysteine (NAC;
40mM), an inhibitor of nuclear factor-úB (NF-úB) and a Reactive Oxygen
Species (ROS) scavenger, respectively, were employed.
Results: Firstly, the exposure of chondrocytes to AA and Oligomycin
signiﬁcantly increased Il-8 mRNA expression in a time- and dose de-
pendent manner. The maximal response was observed at 6 h with a
concentration of 40mg/ml AA and 20mg/ml Oligomycin (1.4×102 and
2.3×102 respectively vs. basal 1 and vs. Il-1b 1.5 ng/ml 3×103). However,
when Il-8 protein expression was examined by cytometry neither AA nor
Oligomycin induced an increasing in the chemokine level after 8 h of
incubation. The positive control, 1.5 ng/ml Il-1b, produced 12.3±2.4 vs
basal 3.9±0.5 (p< 0.01). Secondly, we tested if mitochondrial dysfunction
induced by AA or Oligomycin could modulate the response induced by
Il-1b (1.5 ng/ml) on Il-8 expression, and we found that the pre-treatment
of chondrocytes with 10mg/ml Oligomycin for 2 h increased signiﬁcantly
the expression of Il-8 induced by Il-1b, at both mRNA and protein levels.
The values of Il-8 mRNA expression were 1.9×104 for Oligomycin + Il-1b
vs. 3.0×103 for Il-1b. In relation to Il-8 protein expression the median of
positive cells for Il-8 was 20.7±3.2 for Oligomycin + Il-1b vs. 12.3±2.4
for Il-1b (n = 10; p< 0.01). Furthermore, the values obtained by ELISA
showed similar results (15.8 ng/ml for Il-1b vs 22.9 ng/ml for Oligomycin +
Il-1b). Thirdly, we investigated the role of NF-úB and ROS in this synergic
response and the results showed that the pre-incubation of cells for 2 h
with BAY and NAC reduced to basal levels the production of Il-8 protein
induced by Oligomycin + Il-1b. Similar results were obtained in chondro-
cytes stimulated with other inﬂammatory cytokine, Tumor Necrosis Factor-
a (TNF-a; 10 ng/ml).
Conclusions: These results showed that the dysfunction of mitochondrial
respiratory activity may exacerbate the inﬂammatory response induced by
Il-1b contributing to impair cartilage and joint function in OA and aging.
171 VARIATIONS IN CHONDROCYTE APOPTOSIS MAY EXPLAIN
THE INCREASED PREVALENCE OF OSTEOARTHRITIS IN
SOME JOINTS
C.M. Thomas, C.E. Whittles, C.J. Fuller, M. Sharif. University of Bristol,
Bristol, UNITED KINGDOM
Purpose: Chondrocyte apoptosis correlates with the severity of extra-
cellular matrix damage and is thought to be a key mechanism in the
pathogenesis of osteoarthritis (OA). OA does not affect all synovial
joints equally; the precise reasons for this are unknown. Differences in
chondrocyte response to stimuli between cartilages of different joint types
may contribute to this phenomenon. Hence, the aim of this study was to
investigate whether there are any variations in chondrocyte susceptibility
to an apoptotic stimulus between cells of articular cartilage (AC) from
joints that differ in prevalence of OA, which may provide an alternative
explanation for the joint-speciﬁc nature of the disease.
Methods: Cartilage from macroscopically normal metacarpophalangeal
(MCP), proximal interphalangeal (PIP) and distal interphalangeal (DIP)
joints of seven horses were used. The MCP joint is high-motion and
frequently OA-affected, whilst both DIP and PIP joints are low-motion
and have a reduced incidence of arthritic disease in racehorses. Prior
to culture, chondrocyte viability was assessed using the ﬂuorescein diac-
etate and propidium iodide paravital staining method. AC explants were
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subsequently treated with tumour necrosis factor-a (TNF-a) in combina-
tion with Actinomycin D to induce apoptosis. Apoptotic chondrocytes in
cartilage sections were identiﬁed using an indirect immunohistochemical
staining technique to detect expression of active caspase-3. Haematoxylin
and eosin/safranin-o stained sections were used to score cellularity and
structural differences between samples.
Results: Prior to culture, (mean±standard deviation) chondrocyte via-
bility was 80.7% (3.5). The extent of chondrocyte apoptosis induced
by TNF-a/Actinomycin D varied markedly according to the joint type
that the cartilage was sampled from. For MCP joints, the extent of
overall chondrocyte apoptosis was signiﬁcantly higher (P< 0.001) in TNF-
a/Actinomycin D-stimulated explants (26.7%, 10.3) than that observed in
unstimulated control samples (9.6%, 7.5). Chondrocytes from PIP and
DIP joint cartilage did not respond signiﬁcantly to apoptotic stimulation
(P> 0.05); apoptosis in both control and stimulated explants was virtually
identical. Signiﬁcant variations in cellularity and thickness were evident
between cartilages of different joint types. Cartilage from DIP and PIP
joints was signiﬁcantly thicker than that of the MCP joint (P< 0.001 and
P< 0.05 respectively). Moreover, MCP joint AC was signiﬁcantly more
cellular than both PIP and DIP joints (P< 0.001).
Conclusions: Data in this study demonstrate that chondrocytes from
three equine joint types with varying prevalence’s of OA differ signiﬁcantly
in terms of susceptibility to apoptosis induction. This may provide a
possible explanation for the joint-speciﬁc nature of the disease. Joint-
type dependent differences in cartilage thickness and cellularity may also
have contributory roles.
172 THE CO-RELEASING MOLECULE CORM-2 IS A NOVEL
STRATEGY TO COUNTERACT OXIDATIVE STRESS AND
INFLAMMATION IN OSTEOARTHRITIC CHONDROCYTES
I. Guille´n1, J. Megı´as2, F. Gomar3, M. Alcaraz2. 1Cardenal-Herrera
CEU University, Moncada, SPAIN, 2University of Valencia, Department
of Pharmacology, Valencia, SPAIN, 3University of Valencia, Department
of Surgery, Valencia, SPAIN
Purpose: The production of reactive oxygen species and inﬂammatory
mediators may contribute to the disregulation of cartilage homeostasis
in osteoarthritis (OA). We have shown recently the protective effects
of the CO-releasing molecule (CO-RM) tricarbonyldichlororuthenium (II)
dimer (CORM-2) against OA cartilage degradation, with down-regulation
of catabolic enzymes and enhancement of glycosaminoglycan synthesis.
The objective of the present study was to investigate whether CORM-2
is able to inhibit the production of oxidative stress and the inﬂammatory
response induced by interleukin 1b (Il-1b) in primary human OA chondro-
cytes.
Methods: Cartilage specimens were obtained from 17 patients with
diagnosis of advanced OA undergoing total knee joint replacement.
Chondrocytes were isolated by digestion with collagenase and used in
primary culture. Cells were stimulated with Il-1b (100U/ml) for different
times in the presence or absence of CORM-2 (50, 100 or 150 mM). Protein
expression was investigated by Western blot and immunoﬂuorescence.
Cytokine levels were determined by ELISA and prostaglandin E2 (PGE2)
by RIA. Gene expression was measured by real-time quantitative PCR.
Oxidative stress was assessed by laser scanning cytometry analysis.
Nuclear factor-úB (NF-úB) and hypoxia inducible factor-1a (HIF-1a) DNA
binding was quantitated by ELISA in nuclear extracts.
Results: CORM-2 signiﬁcantly decreased Il-1b-stimulated reactive oxy-
gen species production in OA chondrocytes. The inhibition of oxidative
stress was related to the down-regulation of gp91-phox. In addition,
CORM-2 inhibited tumor necrosis factor-a levels but enhanced Il-1 re-
ceptor antagonist production. Our studies have shown that CORM-2 is
able to control the enhanced synthesis of PGE2 in OA chondrocytes
treated with Il-1b, which can be mainly dependent on the reduction
in microsomal PGE synthase-1 gene expression with minor effects on
cyclooxygenase-2. Il-1b strongly stimulated the binding of HIF-1a to its
consensus sequence, whereas in chondrocytes treated with CORM-2, a
concentration-dependent inhibition was observed. This agent also inhib-
ited NF-úB-DNA binding.
Conclusions: Results from the present study establish the presence of
antioxidative and antiinﬂammatory mechanisms in the beneﬁcial effects
elicited by CORM-2 in OA chondrocytes and cartilage. Our data suggest
that inhibition of NF-úB and HIF-1a activation may play a role in the
inhibitory effects of CORM-2 on the production of mediators relevant in
OA.
173 ROSEMARY EXTRACT INHIBITS GLYCOSAMINOGLYCAN
AND COLLAGEN DEGRADATION IN BOVINE ARTICULAR
CARTILAGE EXPLANTS
F. Scalfo1, S. Davis1, M.A. Karsdal2, E. Offord1, L.G. Ameye1. 1Nestle´
Research Center, Lausanne, SWITZERLAND, 2Nordic Bioscience,
Herlev, DENMARK
Purpose: The objective of the study was to investigate the effects of
rosemary, an herb frequently used in Mediterranean cuisine, and of
carnosol, one of its main antioxidant, on cartilage degradation after
catabolic stimulation.
Methods: In a ﬁrst set of experiments (n = 3), S35-labelled bovine artic-
ular cartilage explants were cultured for 3 days with Il-b in the presence
or absence of various doses of rosemary extract or carnosol (50, 25,
10, 5mg/ml for both). Cell viability was assessed by the release of
lactate deshydrogenase. Glycosaminoglycan degradation was measured
by quantifying the amount of S35 released in the culture media. In
a second set of experiment (n = 1), bovine articular cartilage explants
were cultured for 21 days with oncostatin and TNF-a in the presence
or absence of various doses of rosemary extract (100, 50, 10 mg/ml) or
carnosol (3.31, 1.66, 0.33 mg/ml corresponding to 10, 5 and 1 mM). Cell
viability was assessed by the AlamarBlue assay. MMP mediated collagen
and glycosaminoglycan degradation were assessed by measuring the
amounts of CTX-II and 342FFGVG epitopes released in the culture media
over the 21 days of culture. Aggrecanase mediated aggrecan degradation
was assessed by measuring the amount of 374ARGSV epitope released
in the culture media over the 9 ﬁrst days of culture.
Results: In the ﬁrst set of experiments, rosemary extract, at doses rang-
ing from 50 down to 5mg/ml, and carnosol, at the doses of 10 and 5 mg/ml,
inhibited IL1-b induced S35 release without affecting cell viability. At the
highest doses of 50 and 25mg/ml, carnosol decreased cell viability. In
the second set of experiment, rosemary extract at the lowest tested dose
(10mg/ml) almost completely abolished the MMP mediated degradation
of aggrecan and of type II collagen induced by oncostatin and TNF-a
without affecting the aggreganase mediated aggrecan degradation. At
this low dose, rosemary extract did not affect cell viability contrary to
the 2 highest tested doses (50 and 100mg/ml). Conversely, the 2 lowest
tested doses of carnosol (1.66, 0.33mg/ml) decreased the aggrecanase
mediated aggrecan degradation witouth affecting the MMP mediated
degradation of aggrecan and type II collagen. The highest tested dose of
carnosol (3.31 g/ml) decreased cell viability.
Conclusions: Taken together, these results indicate that rosemary ex-
tract slow down cartilage degeneration in vitro by inhibiting MMP activity.
Preliminary observations suggest that the effects of rosemary extract on
cartilage degeneration are not solely mediated by its content in carnosol
since the anti-catabolic effect of carnosol and rosemary extract on articu-
lar cartilage only partly overlap. These ﬁndings provide a rationale basis
for the in vivo testing of rosemary extract in osteoarthritis.
174 GLUCOSAMINE INTERFERES WITH MITOGEN-ACTIVATED
PROTEIN KINASE PATHWAY BY INHIBITING JNK AND p38
PHOSPHORYLATION, IN HUMAN CHONDROCYTES
A. Scotto d’Abusco1, C. Cicione1, V. Calamia1, B. Grigolo2, L. Politi1,
R. Scandurra1. 1Sapienza, University of Roma, Roma, ITALY , 2Istituto
di Ricerca Codivilla Putti, Istituti Ortopedici Rizzoli, Bologna, ITALY
Purpose: Previous studies demonstrated the ability of Glucosamine
(GlcN) to inhibit mRNA transcription level of Interleukin-1b (Il-1b)-
stimulated genes. These genes are under the control of two transcription
factors Activator Protein (AP)-1 and NF-kB. The aim of this study was to
determine the effects of GlcN on mitogen-activated protein (MAP) kinase
phosphorylation and on activation of AP-1, in human chondrocytes.
Methods: Human immortalized cell line, lbpva55, and human chondro-
cytes, obtained from healthy donors, were challenged with 10 ng/ml Il-1b
cytokine after pre-treatment with 2.5 or 10mM GlcN. mRNA expression
levels of some matrix metalloprotease (MMP) genes were evaluated by
Quantitative-Real Time PCR (Q-RT-PCR), protein production levels were
evaluated in the culture supernatant by Enzyme Linked ImmunoSorbent
Assay (ELISA). MAP kinase phosphorylation was evaluated by Western
Blotting. AP-1 transcription factor activation was evaluated by measuring
AP-1 component DNA binding activity (TransAM AP-1 family kit).
Results: After Il-1b stimulation, MMP-1, -3 and -13 productions were
strongly increased both at mRNA and protein level. Treatment with GlcN
reduced the expression of these metalloproteases. MMP-1, -3 and -13
expression is regulated by transcription factors such as AP-1, which is ac-
tivated by phosphorylated MAP kinases. Il-1b stimulated phosphorylation
